Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Noble Corporation plc (NE) vs Oscar Health Inc (OSCR) Price & Performance

Noble Corporation plcTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

Noble Corporation plc vs Oscar Health Inc — how do they compare? Noble Corporation plc trades at $44.16 (market cap $7.10B), while Oscar Health Inc trades at $29.06 (market cap $8.63B). The key difference: Oscar Health Inc is the larger of the two by market cap, and Noble Corporation plc pays a 4.5% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.

NEOSCR
Market Cap
$7.10B$8.63B
Sector
TechnologyHealth
52-Week High
$54.37$32.18
52-Week Low
$26.61$10.85
Enterprise Value
$8.53B$4.99B
Dividend Yield
4.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Noble Corporation plc

Noble Corporation (NE) trades at $44.48, up 2.14% today, with a bullish technical signal driven by moving averages. The stock shows mixed earnings performance, with a Q1 2026 beat but a Q2 2026 miss, while revenue and net income have declined year-over-year. Recent news highlights multiple law firm investigations into the company, adding uncertainty. The consensus price target is $46.00, slightly above the current price, with analysts divided between Buy (31%) and Hold (43%) ratings.

The outlook is cautious due to earnings volatility and legal scrutiny, though positive cash flow and a solid backlog of $6.8 billion provide some stability. Key risks include operational suspensions and investor litigation, while potential upside hinges on execution improvements and contract wins. The stock's valuation appears stretched with a P/E of 47.32, demanding strong future growth to justify current levels.

Oscar Health Inc

OSCR trades at $27.97, up 1.08% today, with a bearish technical signal but strong recent earnings beats in Q1 and Q2 2026. The company reported record profitability and raised its full-year outlook, driven by membership growth and cost controls. Key support lies at $26, with resistance at $28. Revenue surged 70% year-over-year in H1 2026 to $4.9 billion, per PYMNTS on August 6, 2026.

Outlook is positive due to robust growth and margin expansion, but risks include execution challenges and competitive pressures. Analysts have a consensus price target of $32.50, with 27% buy ratings. The stock offers value with a P/S of 0.53, though net income volatility remains a concern.

Returns comparison

Trailing returns across standard periods

About Noble Corporation plc

Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.

Read more on NE

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR